NovaBay Pharmaceuticals, Inc.

NYSEAM:NBY Stock Report

Market Cap: US$3.7m

NovaBay Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Justin Hall

Chief executive officer

US$364.1k

Total compensation

CEO salary percentage96.1%
CEO tenure8.9yrs
CEO ownership0.001%
Management average tenureno data
Board average tenure4.1yrs

Recent management updates

Recent updates

We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Mar 29
We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Justin Hall's remuneration changed compared to NovaBay Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$17m

Mar 31 2024n/an/a

-US$19m

Dec 31 2023US$364kUS$350k

-US$17m

Sep 30 2023n/an/a

-US$15m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$17m

Dec 31 2022US$365kUS$350k

-US$16m

Sep 30 2022n/an/a

-US$9m

Jun 30 2022n/an/a

-US$5m

Mar 31 2022n/an/a

-US$5m

Dec 31 2021US$796kUS$329k

-US$7m

Sep 30 2021n/an/a

-US$7m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$747kUS$286k

-US$11m

Sep 30 2020n/an/a

-US$13m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$8m

Dec 31 2019US$326kUS$260k

-US$10m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$9m

Dec 31 2018US$572kUS$260k

-US$7m

Sep 30 2018n/an/a

-US$4m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018n/an/a

-US$6m

Dec 31 2017US$665kUS$228k

-US$7m

Compensation vs Market: Justin's total compensation ($USD364.15K) is below average for companies of similar size in the US market ($USD655.65K).

Compensation vs Earnings: Justin's compensation has been consistent with company performance over the past year.

CEO

Justin Hall (46 yo)

8.9yrs

Tenure

US$364,146

Compensation

Mr. Justin M. Hall, Esq. has been General Counsel at NovaBay Pharmaceuticals, Inc. since December 2015, Corporate Secretary since July 16, 2017 and President and Chief Executive Officer since June 17, 2019...

Board Members

NamePositionTenureCompensationOwnership
Justin Hall
President4.3yrsUS$364.15k0.0014%
$ 50.9
Paul Freiman
Independent Chairman22.5yrsUS$78.08k0.0016%
$ 57.9
Yenyou Zheng
Independent Director5.2yrsUS$74.08k0.0015%
$ 56.4
Mijia Wu
Director8.8yrsUS$40.58k0.0015%
$ 56.4
Pedram Hamrah
Member of Ophthalmic Advisory Board9.1yrsno datano data
Swan Sit
Independent Director4.9yrsUS$59.08k0.0015%
$ 56.4
Komal Thakore
Member of the Optometry Advisory Board4yrsno datano data
Amr Kouchouk
Member of the Ophthalmic Advisory Board4yrsno datano data
John Aljian
Member of the Ophthalmic Advisory Board4yrsno datano data
Laura Periman
Member of the Ophthalmic Advisory Board4yrsno datano data
Milap Mehta
Member of the Ophthalmic Advisory Board4yrsno datano data
Melanie Bennett-Sims
Member of the Ophthalmic Advisory Board4yrsno datano data

4.1yrs

Average Tenure

50yo

Average Age

Experienced Board: NBY's board of directors are considered experienced (4.1 years average tenure).